Suven Life Sciences

Suven Life Sciences

Pharmaceuticals, 1100 Cornwall Rd, Hyderabad, New Jersey, 08852, United States, 51-200 Employees

suven.com

  • LinkedIn

phone no Phone Number: 91**********

Who is SUVEN LIFE SCIENCES

A Biopharmaceutical company, engaged in Drug Discovery and Development of New Chemical Entities (NCEs) in Central Nervous System (CNS) disorders targeting unmet medical needs, globally. S...

Read More

map
  • 1100 Cornwall Rd, Hyderabad, New Jersey, 08852, United States Headquarters: 1100 Cornwall Rd, Hyderabad, New Jersey, 08852, United States
  • 1989 Date Founded: 1989
  • 51-200 Employees: 51-200
  • dollar-icon Revenue: $10 Million to $25 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Pharmaceuticals

SIC SIC Code: 2834 | NAICS Code: 621320 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from SUVEN LIFE SCIENCES

Suven Life Sciences Org Chart and Mapping

Employees

Michael Eastep

Director Project Management

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Suven Life Sciences

Answer: Suven Life Sciences's headquarters are located at 1100 Cornwall Rd, Hyderabad, New Jersey, 08852, United States

Answer: Suven Life Sciences's phone number is 91**********

Answer: Suven Life Sciences's official website is https://suven.com

Answer: Suven Life Sciences's revenue is $10 Million to $25 Million

Answer: Suven Life Sciences's SIC: 2834

Answer: Suven Life Sciences's NAICS: 621320

Answer: Suven Life Sciences has 51-200 employees

Answer: Suven Life Sciences is in Pharmaceuticals

Answer: Suven Life Sciences contact info: Phone number: 91********** Website: https://suven.com

Answer: A Biopharmaceutical company, engaged in Drug Discovery and Development of New Chemical Entities (NCEs) in Central Nervous System (CNS) disorders targeting unmet medical needs, globally. Suven discovery research is focused on discovering and developing new chemical entities (NCEs), which are best in class central nervous system therapies for the treatment of cognitive disorders, major depressive disorders, sleep disorders, psychiatric disorders, pain and inflammation, gastrointestinal motility disorders. Research targets include serotonin 6 receptor, serotonin 4 receptor, histamine 3 receptor, Nicotinic acetylcholine (Alpha4beta2) receptor, muscarinic M1 receptor, muscarinic M4 receptor, multimodal (Dopaminergic and serotonergic receptor), and P2X purinoceptor 7 receptor

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access